piribedil has been researched along with Arteriosclerosis in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solé, P | 1 |
| Rigal, D | 1 |
| Bacin, F | 1 |
| Perdriel, G | 1 |
| Chevaleraud, JP | 1 |
| Decroix, G | 1 |
2 other studies available for piribedil and Arteriosclerosis
| Article | Year |
|---|---|
[Therapeutic use of piribedil in vascular diseases of the eye].
Topics: Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Eye; Eye Diseases | 1976 |
[Value of piribedil in the treatment of degenerative retinal vasculopathies].
Topics: Adult; Aged; Arteriosclerosis; Choroid; Drug Evaluation; Follow-Up Studies; Humans; Long-Term Care; | 1974 |